MedTrace Logo

Impact of Milk Fat Globule Membrane Supplementation on Heart and Brain Health

NCT05939544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-10-16

No results posted yet for this study

Summary

In a randomised, controlled cross-over manner, this trial aims to determine how short-term daily supplementation with a milk fat globule membrane-enriched ingredient impacts on cardiometabolic health and cognitive outcomes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Experimental: Milk Fat Globule Membrane-enriched Powdered Ingredient

Milk Fat Globule Membrane-enriched Powdered Ingredient

DIETARY_SUPPLEMENT

Placebo Comparator: Control (Placebo) Powdered Ingredient

Placebo Comparator: Control (Placebo) Powdered Ingredient

Sponsors & Collaborators

  • Loughborough University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2024-09-24
Completion
2024-09-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05939544 on ClinicalTrials.gov